0NES.L
Oriola Oyj [0NES.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0NES.L Stock Summary
Top 10 Correlated ETFs
0NES.L
Top 10 Correlated Stocks
0NES.L
In the News
0NES.L Financial details
Company Rating
Strong Buy
Market Cap
1.91M
Income
-26M
Revenue
1.47B
Book val./share
0.96
Cash/share
0.72
Dividend
0.06
Dividend %
5.67%
Employees
754
Optionable
No
Shortable
Yes
Earnings
-
P/E
-7.38
Forward P/E
-
PEG
0.18
P/S
-
P/B
1.1
P/C
1.46
P/FCF
0.14
Quick Ratio
0.55
Current Ratio
0.8
Debt / Equity
0.18
LT Debt / Equity
0.18
-
-
EPS (TTM)
-0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-44.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.94%
Revenue last 5Y
-0.47%
Revenue Q/Q
-8.08%
EPS Q/Q
-1766.67%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-13%
ROC
-0.04%
Gross Margin
11%
Oper. Margin
-1%
Profit Margin
-2%
Payout
-70%
Shs Outstand
1.82M
Shs Float
132.62M
-
-
-
-
Target Price
-
52W Range
0.894-1.828
52W High
-
52W Low
-
RSI
69
Rel Volume
0.69
Avg Volume
32.22K
Volume
22.21K
Perf Week
0.77%
Perf Month
13.3%
Perf Quarter
-21.79%
Perf Half Y
-23.61%
-
-
-
-
Beta
0.624
-
-
Volatility
0.01%, 0.05%
Prev Close
-0.19%
Price
1.04801
Change
-1.13%
0NES.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 8.56 | 8.61 | 9.56 | 8.01 | 8.36 | |
| Net income per share | 0.06 | 0.04 | 0.06 | 0.05 | 0.03 | |
| Operating cash flow per share | 0.57 | 0.42 | 0.31 | 0.22 | 0.43 | |
| Free cash flow per share | 0.45 | 0.32 | 0.17 | 0.09 | 0.38 | |
| Cash per share | 0.36 | 0.35 | 0.89 | 0.6 | 0.89 | |
| Book value per share | 0.98 | 0.79 | 0.9 | 1.2 | 1.24 | |
| Tangible book value per share | -0.89 | -0.9 | -0.86 | -0.58 | 0.8 | |
| Share holders equity per share | 0.98 | 0.79 | 0.9 | 1.2 | 1.24 | |
| Interest debt per share | 0.33 | 0.29 | 0.35 | 0.35 | 0.33 | |
| Market cap | 372.7M | 409.75M | 358.96M | 363.59M | 315.59M | |
| Enterprise value | 306.9M | 338.95M | 190.76M | 254.49M | 154.99M | |
| P/E ratio | 34.51 | 51.22 | 31.77 | 42.28 | 65.75 | |
| Price to sales ratio | 0.24 | 0.24 | 0.2 | 0.25 | 0.21 | |
| POCF ratio | 3.63 | 4.85 | 6.16 | 9.09 | 4.05 | |
| PFCF ratio | 4.55 | 6.48 | 11.51 | 21.9 | 4.55 | |
| P/B Ratio | 2.1 | 2.61 | 2.12 | 1.68 | 1.4 | |
| PTB ratio | 2.1 | 2.61 | 2.12 | 1.68 | 1.4 | |
| EV to sales | 0.2 | 0.2 | 0.11 | 0.18 | 0.1 | |
| Enterprise value over EBITDA | 6.43 | 7.67 | 4.41 | 10.69 | 5.06 | |
| EV to operating cash flow | 2.99 | 4.02 | 3.27 | 6.36 | 1.99 | |
| EV to free cash flow | 3.74 | 5.36 | 6.11 | 15.33 | 2.23 | |
| Earnings yield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 | |
| Free cash flow yield | 0.22 | 0.15 | 0.09 | 0.05 | 0.22 | |
| Debt to equity | 0.33 | 0.37 | 0.39 | 0.29 | 0.26 | |
| Debt to assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Net debt to EBITDA | -1.38 | -1.6 | -3.88 | -4.58 | -5.25 | |
| Current ratio | 0.74 | 0.73 | 0.75 | 0.77 | 0.84 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 9.52 | 10.55 | 5.16 | 3.54 | -32.46 | |
| Dividend Yield | 0.04 | 0.04 | 0.05 | 0.01 | 0.02 | |
| Payout ratio | 1.51 | 2.04 | 1.44 | 0.63 | 1.52 | |
| Sales general and administrative to revenue | 0 | 0.11 | 0.1 | 0.05 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.37 | 0.33 | 0.28 | 0.29 | 0.08 | |
| Capex to operating cash flow | -0.2 | -0.25 | -0.46 | -0.59 | -0.11 | |
| Capex to revenue | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | |
| Capex to depreciation | -0.86 | -0.51 | -0.66 | -1.55 | -0.56 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.15 | 0.84 | 1.1 | 1.13 | 0.86 | |
| ROIC | 0.06 | 0.08 | 0.07 | 0.04 | 0.05 | |
| Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham Net | -2.43 | -2.72 | -2.98 | -2.79 | -1.82 | |
| Working capital | -172.5M | -197M | -206.2M | -168.7M | -106.2M | |
| Tangible asset value | -162.2M | -180.2M | -161.5M | -105.4M | 144.5M | |
| Net current asset value | -262.1M | -352.7M | -367.7M | -322.5M | -193.5M | |
| Invested capital | 0.33 | 0.37 | 0.39 | 0.29 | 0.26 | |
| Average receivables | 200.35M | 183.8M | 188M | 191.65M | 210.75M | |
| Average payables | 531M | 571.6M | 613.5M | 606M | 574.5M | |
| Average inventory | 208.7M | 221.9M | 242.15M | 239.65M | 188.85M | |
| Days sales outstanding | 42.37 | 39.73 | 38.22 | 48.94 | 54.6 | |
| Days payables outstanding | 162.37 | 162.29 | 157.37 | 170.74 | 152.99 | |
| Days of inventory on hand | 63.44 | 62.65 | 63.45 | 66.14 | 40.77 | |
| Receivables turnover | 8.61 | 9.19 | 9.55 | 7.46 | 6.68 | |
| Payables turnover | 2.25 | 2.25 | 2.32 | 2.14 | 2.39 | |
| Inventory turnover | 5.75 | 5.83 | 5.75 | 5.52 | 8.95 | |
| ROE | 0.06 | 0.05 | 0.07 | 0.04 | 0.02 | |
| Capex per share | -0.11 | -0.11 | -0.14 | -0.13 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.06 | 2.07 | 1.96 | 2.11 | 1.94 | |
| Net income per share | 0.03 | -0.04 | 0.01 | 0.01 | -0.11 | |
| Operating cash flow per share | -0.14 | 0.2 | -0.23 | 0.11 | 0.06 | |
| Free cash flow per share | -0.15 | 0.16 | -0.24 | 0.1 | 0.05 | |
| Cash per share | 0.68 | 0.89 | 0.66 | 0.71 | 0.72 | |
| Book value per share | 1.28 | 1.24 | 1.18 | 1.07 | 0.96 | |
| Tangible book value per share | 0.78 | 0.8 | 0.74 | 0.63 | 0.64 | |
| Share holders equity per share | 1.28 | 1.24 | 1.18 | 1.07 | 0.96 | |
| Interest debt per share | 0.33 | 0.33 | 0.32 | 0.18 | 0.17 | |
| Market cap | 323.95M | 315.6M | 256.28M | 234.01M | 166.8M | |
| Enterprise value | 200.55M | 155M | 137.18M | 105.61M | 36.5M | |
| P/E ratio | 15.28 | -9.74 | 58.25 | 48.75 | -2.06 | |
| Price to sales ratio | 0.87 | 0.84 | 0.72 | 0.61 | 0.47 | |
| POCF ratio | -12.51 | 8.74 | -6.02 | 12.19 | 16.51 | |
| PFCF ratio | -11.74 | 10.63 | -5.95 | 13 | 17.94 | |
| P/B Ratio | 1.4 | 1.4 | 1.19 | 1.21 | 0.96 | |
| PTB ratio | 1.4 | 1.4 | 1.19 | 1.21 | 0.96 | |
| EV to sales | 0.54 | 0.41 | 0.39 | 0.28 | 0.1 | |
| Enterprise value over EBITDA | 21.56 | 27.68 | 22.13 | 17.9 | -2.57 | |
| EV to operating cash flow | -7.74 | 4.29 | -3.22 | 5.5 | 3.61 | |
| EV to free cash flow | -7.27 | 5.22 | -3.18 | 5.87 | 3.92 | |
| Earnings yield | 0.02 | -0.03 | 0 | 0.01 | -0.12 | |
| Free cash flow yield | -0.09 | 0.09 | -0.17 | 0.08 | 0.06 | |
| Debt to equity | 0.26 | 0.26 | 0.27 | 0.17 | 0.18 | |
| Debt to assets | 0.06 | 0.06 | 0.06 | 0.03 | 0.03 | |
| Net debt to EBITDA | -13.27 | -28.68 | -19.21 | -21.76 | 9.18 | |
| Current ratio | 1.17 | 0.84 | 0.82 | 0.79 | 0.8 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | -1.77 | -0.95 | -38.73 | 16 | -0.5 | |
| Dividend Yield | 0 | 0.02 | 0 | 0.05 | 0 | |
| Payout ratio | 0 | -0.9 | 0 | 9.08 | 0 | |
| Sales general and administrative to revenue | 0 | 0.05 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.08 | 0.08 | 0.08 | 0.09 | 0.06 | |
| Capex to operating cash flow | 0.07 | -0.18 | 0.01 | -0.06 | -0.08 | |
| Capex to revenue | 0 | -0.02 | 0 | 0 | 0 | |
| Capex to depreciation | -0.44 | -1.56 | -0.14 | -0.33 | -0.21 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.92 | 1.12 | 0.4 | 0.4 | 1.55 | |
| ROIC | 0.02 | 0.01 | 0.01 | 0.01 | -0.09 | |
| Return on tangible assets | 0.01 | -0.01 | 0 | 0 | -0.02 | |
| Graham Net | -2.83 | -1.82 | -1.93 | -1.89 | -1.9 | |
| Working capital | 131.7M | -106.2M | -114.8M | -141.2M | -136.6M | |
| Tangible asset value | 142.1M | 144.5M | 134.1M | 113.9M | 116.5M | |
| Net current asset value | 37M | -193.5M | -199.7M | -195.9M | -188.6M | |
| Invested capital | 0.26 | 0.26 | 0.27 | 0.17 | 0.18 | |
| Average receivables | 192.15M | 204.85M | 238.1M | 249.55M | 249.8M | |
| Average payables | 565.55M | 546.6M | 550.7M | 551.65M | 568.15M | |
| Average inventory | 155.1M | 151.65M | 155.8M | 160.25M | 165.5M | |
| Days sales outstanding | 44.03 | 54.46 | 63.28 | 58.58 | 63.79 | |
| Days payables outstanding | 147.27 | 152.18 | 156.6 | 146.6 | 164.62 | |
| Days of inventory on hand | 42.54 | 40.55 | 46.94 | 41.26 | 49.52 | |
| Receivables turnover | 2.04 | 1.65 | 1.42 | 1.54 | 1.41 | |
| Payables turnover | 0.61 | 0.59 | 0.57 | 0.61 | 0.55 | |
| Inventory turnover | 2.12 | 2.22 | 1.92 | 2.18 | 1.82 | |
| ROE | 0.02 | -0.04 | 0.01 | 0.01 | -0.12 | |
| Capex per share | -0.01 | -0.04 | 0 | -0.01 | 0 |
0NES.L Frequently Asked Questions
What is Oriola Oyj stock symbol ?
Oriola Oyj is a FI stock and trading under the symbol 0NES.L
What is Oriola Oyj stock quote today ?
Oriola Oyj stock price is $1.04801 today.
Is Oriola Oyj stock public?
Yes, Oriola Oyj is a publicly traded company.
Company Profile
- Volume Average 32.22K
- Market Capitalization 1.91M
- Employee 754
- CEO Ms. Katarina Gabrielson M.Sc.
- Headquarters Espoo,FI
- IPO Date 2008-01-09
-
Website
https://www.oriola.com 
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well as the grocery trade shops. In addition, the company offers pharmaceutical staffing and dose dispensing services for public and private healthcare operators, pharmacies, groceries, veterinarians, and retailers. As of December 31, 2021, it operated 319 pharmacies in Sweden, as well as operates online pharmacies. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. Oriola Oyj is headquartered in Espoo, Finland.
